Europe - Euronext Paris - EPA:BIM - FR0013280286 - Common Stock
BIM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 67 industry peers in the Health Care Equipment & Supplies industry. BIM is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BIM has a decent growth rate and is not valued too expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.04% | ||
| ROE | 9.61% | ||
| ROIC | 8.56% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.38% | ||
| PM (TTM) | 9.17% | ||
| GM | 56.27% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 1.15 | ||
| Altman-Z | 6.58 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.27 | ||
| Quick Ratio | 1.3 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.87 | ||
| Fwd PE | 20.47 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.97 | ||
| EV/EBITDA | 12.67 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.85% |
ChartMill assigns a fundamental rating of 6 / 10 to BIM.PA.
ChartMill assigns a valuation rating of 4 / 10 to BIOMERIEUX (BIM.PA). This can be considered as Fairly Valued.
BIOMERIEUX (BIM.PA) has a profitability rating of 6 / 10.
The financial health rating of BIOMERIEUX (BIM.PA) is 8 / 10.
The dividend rating of BIOMERIEUX (BIM.PA) is 3 / 10 and the dividend payout ratio is 28.07%.